Mylan granted approval for generic Avalide tablets

Jun 17, 2008 (Datamonitor via COMTEX) -- AVE | Quote | Chart | News | PowerRating -- Mylan has announced that its subsidiary, Mylan Pharmaceuticals, has received tentative approval from the FDA for its abbreviated new drug application for Irbesartan and hydrochlorothiazide tablets, 150mg/12.5mg and 300mg/12.5mg.

Irbesartan and hydrochlorothiazide tablets, indicated for the treatment of hypertension, are the generic version of Sanofi Aventis's Avalide tablets.

Currently, Mylan has 92 abbreviated new drug applications pending FDA approval, 20 of which are potential first-to-file opportunities.

http://www.datamonitor.com

Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Datamonitor shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon

Morning Coffee with TradingMarkets -- Free Newsletter

More News:   Market Updates | Stock Alerts | All Trading News | Stock Index